What conditions does Beijing GoBroad Hospital run trials for?

In our tracked recruiting trials, Beijing GoBroad Hospital sponsors trials for Lupus, Systemic Lupus Erythematosus (SLE), Hypertension.

Clinical trials sponsored by Beijing GoBroad Hospital

Recruiting trials

Conditions studied

Phase 1 5Phase 2 3

Condition	Trials
Lupus	5
Systemic Lupus Erythematosus (SLE)	3
Hypertension	2
Primary Sjogren's Syndrome Combined With Pulmonary Hypertension	2
Refractory Lupus Nephritis	2
Systemic Sclerosis	2
Systemic Sclerosis (SSc)	2
ANCA Associated Vasculitis (AAV)	1
Idiopathic Inflammatory Myopathy (IIM)	1
Lupus Nephritis (LN)	1
Other Autoimmune Diseases (AID)	1

A Study of OL-108 in Relapsed/Refractory Autoimmune Diseases
NCT06980597 · Phase: Phase 1 · Ages: 18 Years to 65 Years · Sex: All (male and female) · 2 locations
Anti-CD19 Chimeric Antigen Receptor T Cells for Refractory Systemic Lupus Erythematosus
NCT06585514 · Phase: Phase 1, Phase 2 · Ages: 3 Years to 65 Years · Sex: All (male and female) · 1 location
CD19-BCMA CART Cell Therapy for Refractory SLE-LN, SSc, and pSS-PAH
NCT06947460 · Phase: Phase 1, Phase 2 · Ages: 10 Years to 65 Years · Sex: All (male and female) · 1 location
CT1190B in the Treatment of Patients With Moderate to Severe Refractory Systemic Lupus Erythematosus (SLE) or Refractory/Progressive Systemic Sclerosis (SSc)
NCT06822881 · Phase: Phase 1 · Ages: 18 Years to 60 Years · Sex: All (male and female) · 1 location
Umbilical Cord Blood CD19-BCMA CART Cell Therapy for SLE-LN, SSc, andpSS PAH.
NCT06947473 · Phase: Phase 1, Phase 2 · Ages: 6 Years to 65 Years · Sex: All (male and female) · 1 location